Cabergoline Tablets USP 0,5 mg Ingenus Pharmaceuticals
Overview of Cabergoline Tablets USP 0,5 mg Ingenus Pharmaceuticals, history and composition
Cabergoline Tablets USP 0.5 mg by Ingenus Pharmaceuticals are a medication primarily used to treat conditions associated with elevated levels of prolactin, such as prolactinomas. Developed in the late 20th century, cabergoline is a dopamine agonist that stimulates dopamine receptors, thereby inhibiting the secretion of prolactin from the anterior pituitary gland. This medication is composed of cabergoline as the active ingredient, along with excipients that provide stability and aid in the absorption of the drug. The low dosage of 0.5 mg is particularly advantageous for patients requiring precise control over their prolactin levels. Ingenus Pharmaceuticals is known for its high manufacturing standards, ensuring that the tablets meet rigorous quality criteria consistent with USP guidelines.
Physiological impact, what happens in the body
When ingested, cabergoline acts on the central nervous system, engaging D2 dopamine receptors. This interaction leads to a reduction in prolactin levels in the bloodstream. The physiological impact is significant, as elevated prolactin can lead to various issues, including infertility, menstrual irregularities, and unwanted lactation. Furthermore, cabergoline’s mechanism of action may promote increased testosterone levels in men and improve fertility rates. Patients generally experience rapid symptom relief, which can significantly enhance quality of life. Adhering to the prescribed regimen is crucial, as fluctuations in prolactin can lead to a resurgence of symptoms.
How to acquire Cabergoline Tablets USP 0,5 mg Ingenus Pharmaceuticals, purchasing instructions
Acquiring Cabergoline Tablets USP 0.5 mg requires a prescription from a licensed healthcare provider. Patients should consult their doctor to discuss symptoms related to high prolactin levels and determine whether cabergoline is the appropriate medication. Upon receiving a prescription, it can be filled at most pharmacies or online platforms that comply with local regulations. It is essential to purchase from reputable sources to ensure the authenticity and safety of the medication. Always follow the dosage and usage instructions provided by your healthcare provider for optimal results.
Contraindications, who should avoid it
While cabergoline is an effective treatment, it is not suitable for everyone. Individuals with a history of hypersensitivity to cabergoline or any of its excipients should avoid this medication. Additionally, those with severe cardiovascular disorders, psychiatric conditions, or liver dysfunction should consult their physician prior to use. Pregnant or breastfeeding women are also advised to exercise caution and discuss potential risks with their healthcare provider, as cabergoline may have implications for fetal and neonatal health.
Key effects, main reasons for use
The primary use of Cabergoline Tablets USP 0.5 mg is to manage elevated prolactin levels and treat disorders related to prolactinomas. Key effects of cabergoline include:
- Reduction of prolactin levels in the bloodstream
- Improvement in menstrual regularity
- Enhancement of fertility in both men and women
- Decrease in symptoms of hyperprolactinemia, such as galactorrhea
- Possible increase in testosterone levels in men
These benefits make cabergoline a go-to option for individuals struggling with prolactin-related issues, paving the way for a more normal and healthy lifestyle.
| Active substance | Cabergoline |
|---|---|
| Water Retention | No significant impact on water retention |
| Hepatotoxicity | Low risk, but liver function monitoring is advised for prolonged use |
| Lab Test | Blood prolactin levels |
| Also known as | Cabaser, Dostinex |
| Blood pressure | May cause hypotension (lower blood pressure) |
| Trade name | Dostinex, Cabaser |
| Storage conditions | Store at room temperature, protect from light and moisture |
| Chemical name | 1-[(6-allylergolin-8ОІ-yl)-carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea |
| Formula | C26H37N5O2 |
| Substance class | Ergoline derivative |
| Main action | Dopamine D2 receptor agonist |
| Half-life | 63 to 68 hours |
| Dosage (medical) | Typically 0.25 mg to 1 mg twice a week for hyperprolactinemia |
| Dosage (sports) | Not officially recommended for sports uses, typically around 0.25 mg to 0.5 mg per week when used |
| Effects | Decreases prolactin levels, can potentially enhance mood and libido |
| Side effects | Nausea, headache, dizziness, orthostatic hypotension, constipation, fatigue, heart valve issues in higher doses |
| Use in sports | Primarily used to reduce prolactin-related side effects of anabolic steroids |
| Active ingredient, mg | 0.5 |
| Release form | Pack (8 Pills) |
| 1 Pill, mg | 0.5 |
| Manufacturer | Ingenus Pharmaceuticals |
| Packing | Vial (8 tablets) |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |



Reviews
There are no reviews yet.